GNIPST Bulletin 37.1

8/11/2019 GNIPST Bulletin 37.1

1/17

29-08-2014GG NN II PP SS TT UU LL LL TT II NN 22 11 44

29 th August, 2014 Volume No.: 37 Issue No.: 01Vision

TO REACH THE PINNACLE OF GLORY AS A CENTRE OF EXCELLENCE IN THE FIELOF PHARMACEUTICAL AND BIOLOGICAL SCIENCES BY KNOWLEDGE BASED

LEARNING AND PRACTICE

ontentsMessage from PRINCIPALEditorial boardHistorical article

News UpdateKnowledge based ArticleDisease Related BreakingNewsUpcoming EventsDrugs Update

Campus NewsStudents SectionEditors NoteArchive

GNIPST Photo Galleryor your comments/contributionR For ack-Issues , ailto:[email protected]

GURU NANAK INSTITUTE OF PHARMACEUTICALSCIENCE AND TECHNOLOGY

We b si t e : ht t p: / / gni ps t. a c. i n
https://plus.google.com/u/0/photos/111714720327580099858/albums/5897323676427099873?sort=7mailto:[email protected]:[email protected]:[email protected]://plus.google.com/u/0/photos/111714720327580099858/albums/5897323676427099873?sort=7


2/17

29-08-2014

MESSAGE FROM PRINCIPAL

" It can happen. It does happen. But it can't happen if you quit ." Lauren Dane.

We are what we repeatedly do. Excellence then is not an act, but a habit . Aristotle

It gives me immense pleasure to pen a few words for our e-bulletin. At the onset I would like to thank thelast years editors and congratulate the newly selected editors for the current year.

Our first consideration is always in the best interest of the students. Our goal is to promote academicexcellence and continuous improvement.

I believe that excellence in education is aided by creating a learning environment in which all learners aresupported in maximizing their potential and talents. Education needs to focus on personalized learningand instruction, while promoting an education system that is impartial, universally accessible, and meetingthe needs of all students.

It is of paramount importance that our learners have sufficient motivation and encouragement in order toachieve their aims. We are all very proud of you, our students, and your accomplishments and lookforward to watching as you put your mark on the profession in the years ahead.

The call of the time is to progress, not merely to move ahead. Our progressive Management is lookingforward and wants our Institute to flourish as a Post Graduate Institute of Excellence. Steps are taken inthis direction and fruits of these efforts will be received by our students in the near future. Our Teachersare committed and dedicated for the development of the institution by imparting their knowledge and playthe role of facilitator as well as role model to our students.

The Pharmacy profession is thriving with a multitude of possibilities, opportunities and positivechallenges. At Guru Nanak Institute of Pharmaceutical Science and Technology, our focus is on holisticneeds of our students.

I am confident that the students of GNIPST will recognize all the possibilities, take full advantage of theopportunities and meet the challenges with purpose and determination.

Excellence in Education is not a final destination, it is a continuous walk. I welcome you to join us onthis path.

My best wishes to all.

Dr. A. Sengupta

Click here to go at the top

1


3/17

29-08-2014

EDITORIAL BOARD

CHIEF EDITOR DR. ABHIJIT SENGUPTAEDITOR MS. JEENATARA BEGUMASSOCIATE EDITOR MR. DIPANJAN MANDAL

HISTORICAL ARTICLE

Dioscorides A Scientist Looks at Drugs In the evolution of all successful and enduring systems ofknowledge there comes a time when the observations of manymen, or the intensive studies of one, transcend from the level of

trade or vocation to that of a science. Pedanios Dioscorides (firstcentury A.D.), contributed mightily to such a transition inPharmacy. In order to study materiamedica, Dioscoridesaccompanied the Roman armies throughout the known world. Herecorded what he observed, promulgated excellent rules forcollection of drugs, their storage and use. His texts wereconsidered basic science as late as the sixteenth century.

NEWS UPDATE

Genomic sequencing reveals mutations, insightsinto 2014 Ebola outbreak: (28 th August, 2014)In response to an ongoing, unprecedented outbreak of Ebola virusdisease in West Africa, a team of researchers has rapidly sequencedand analyzed more than 99 Ebola virus genomes. Their findingscould have important implications for rapid field diagnostic tests.


2


4/17

29-08-2014

Electric current to brain boosts memory: Mayhelp treat memory disorders from stroke,Alzheimer's, brain injury: (28 th August, 2014)Stimulating a region in the brain via non-invasive delivery ofelectrical current using magnetic pulses, called TranscranialMagnetic Stimulation, improves memory. The discovery opens anew field of possibilities for treating memory impairments causedby conditions such as stroke, early-stage Alzheimer's disease,traumatic brain injury, cardiac arrest and the memory problemsthat occur in healthy aging. Home is where the microbes are: (28 th August,2014)A person's home is their castle, and they populate it with theirown subjects: millions and millions of bacteria. Scientists havedetailed the microbes that live in houses and apartments. Theresults shed light on the complicated interaction between humansand the microbes that live on and around us. Mounting evidencesuggests that these microscopic, teeming communities play a role

in human health and disease treatment and transmission. From bite site to brain: How rabies virus hijacksand speeds up transport in nerve cells: (28 th

August, 2014)Rabies is usually transmitted through the bite of an infectedanimal into muscle tissue of the new host. From there, the virustravels all the way to the brain where it multiplies and causes theusually fatal disease. A new article sheds light on how the virushijacks the transport system in nerve cells to reach the brain withmaximal speed and efficiency.


3


5/17

29-08-2014

Small molecule acts as on-off switch fornature's antibiotic factory: Tells Streptomycesto either veg out or get busy: (28 th August,2014) Biochemists have identified the developmental on-off switch forStreptomyces, a group of soil microbes that produce more thantwo-thirds of the world's naturally derived antibiotic medicines.Their hope now would be to see whether it is possible tomanipulate this switch to make nature's antibiotic factory moreefficient.

Up to 3,000 times the bacterial growth onhollow-head toothbrushes: (28 th August, 2014)Solid-head power toothbrushes retain less bacteria compared tohollow-head toothbrushes, according to new research. Synthesis produces new fungus-derivedantibiotic: (28 th August, 2014)A fortuitous collaboration has led to the total synthesis of arecently discovered natural antibiotic. The laboratory recreation ofa fungus-derived antibiotic, viridicatumtoxin B, may someday helpbolster the fight against bacteria that evolve resistance totreatments in hospitals and clinics around the world. Indoor mold poses health risk to asthmasufferers: (28 th August, 2014)By critically reviewing the findings from 17 studies in eight

different countries, the research has found that the presence ofseveral types of mould can lead to breathing problems in asthmasufferers, as well as increasing the likelihood of developing thecondition.


4


6/17

29-08-2014

Readers with dyslexia have disrupted networkconnections in the brain, map the circuitry ofdyslexia shows: (28 th August, 2014) Dyslexia, the most commonly diagnosed learning disability in theUnited States, is a neurological reading disability that occurs whenthe regions of the brain that process written language don'tfunction normally. The use of non-invasive functionalneuroimaging tools has helped characterize how brain activity isdisrupted in dyslexia. However, most prior work has focused ononly a small number of brain regions, leaving a gap in ourunderstanding of how multiple brain regions communicate with

one another through networks, called functional connectivity, inpersons with dyslexia. Scientists have now conducted a whole-brain functional connectivity analysis of dyslexia using functionalmagnetic resonance imaging (fMRI). From nose to knee: Engineered cartilageregenerates joints: (28 th August, 2014)Human articular cartilage defects can be treated with nasal septumcells. Researchers now report that cells taken from the nasalseptum are able to adapt to the environment of the knee joint andcan thus repair articular cartilage defects. The nasal cartilage cells'ability to self-renew and adapt to the joint environment isassociated with the expression of so-called HOX genes. Three-quarters of depressed cancer patients donot receive treatment for depression; newapproach could transform care: (27 th August,2014)Three papers reveal that around three-quarters of cancer patientswho have major depression are not currently receiving treatmentfor depression, and that a new integrated treatment program isstrikingly more effective at reducing depression and improvingquality of life than current care.


5


7/17

29-08-2014

For detail mail to editor

KNOWLEDGE BASED ARTICLE

Ebola Virus DiseaseEbola first appeared in 1976 in 2 simultaneous outbreaks, in Nzara,Sudan, and in Yambuku, Democratic Republic of Congo. The latterwas in a village situated near the Ebola River, from which thedisease takes its name.Genus Ebolavirus is 1 of 3 members of theFiloviridae family(filovirus), along with genus Marburgvirus and genus Cuevavirus.

Genus Ebolavirus comprises 5 distinct species:Bundibugyo ebolavirus (BDBV)Zaire ebolavirus (EBOV)Reston ebolavirus (RESTV)Sudan ebolavirus (SUDV)Ta Forest ebolavirus (TAFV).BDBV, EBOV, and SUDV have been associated with large EVDoutbreaks in Africa, whereas RESTV and TAFV have not. TheRESTV species, found in Philippines and the Peoples Republic ofChina, can infect humans, but no illness or death in humans fromthis species has been reported.TransmissionEbola is introduced into the human population through closecontact with the blood, secretions, organs or other bodily fluids ofinfected animals. In Africa, infection has been documented throughthe handling of infected chimpanzees, gorillas, fruit bats, monkeys,forest antelope and porcupines found ill or dead or in the

rainforest.Ebola then spreads in the community through human-to-humantransmission, with infection resulting from direct contact(through broken skin or mucous membranes) with the blood,secretions, organs or other bodily fluids of infected people, andindirect contact with environments contaminated with such


6
mailto:[email protected]:[email protected]:[email protected]


8/17

29-08-2014

fluids. Burial ceremonies in which mourners have direct contactwith the body of the deceased person can also play a role in thetransmission of Ebola. Men who have recovered from the diseasecan still transmit the virus through their semen for up to 7 weeksafter recovery from illness.Health-care workers have frequently been infected while treatingpatients with suspected or confirmed EVD. This has occurredthrough close contact with patients when infection controlprecautions are not strictly practiced.Among workers in contact with monkeys or pigs infected withReston ebolavirus, several infections have been documented inpeople who were clinically asymptomatic. Thus, RESTV appears

less capable of causing disease in humans than other Ebola species.However, the only available evidence available comes from healthyadult males. It would be premature to extrapolate the healtheffects of the virus to all population groups, such as immuno-compromised persons, persons with underlying medicalconditions, pregnant women and children. More studies of RESTVare needed before definitive conclusions can be drawn about thepathogenicity and virulence of this virus in humans.Signs and symptomsEVD is a severe acute viral illness often characterized by thesudden onset of fever, intense weakness, muscle pain, headacheand sore throat. This is followed by vomiting, diarrhoea, rash,impaired kidney and liver function, and in some cases, bothinternal and external bleeding. Laboratory findings include lowwhite blood cell and platelet counts and elevated liver enzymes.People are infectious as long as their blood and secretions containthe virus. Ebola virus was isolated from semen 61 days after onset

of illness in a man who was infected in a laboratory.The incubation period, that is, the time interval from infectionwith the virus to onset of symptoms, is 2 to 21 days.


7


9/17

29-08-2014

ReservoirBatsare considered the most likely natural reservoir of the EBOV;plants, arthropods, and birds have also been considered. Bats were

known to reside in the cotton factory in which the first casesforthe 1976 and 1979 outbreaks were employed, and they have alsobeen implicated in Marburg virus infections in 1975 and 1980. Of24 plant species and 19 vertebrate species experimentallyinoculated with EBOV, only bats became infected. The absence ofclinical signs in these bats is characteristic of a reservoir species. Ina 20022003 survey of 1,030 animals including 679 batsfrom Gabon and the Republic of the Congo, 13 fruit bats were foundto contain EBOV RNA fragments. As of 2005, three types of fruitbats (Hypsignathus monstrosus, Epomops franqueti, and Myonycteristorquata) have been identified as being in contact with EBOV. Theyare now suspected to represent the EBOV reservoirhosts. Antibodies against Ebola Zaire and Reston viruses havebeen found in fruit bats in Bangladesh, thus identifying potentialvirus hosts and signs of the filoviruses in Asia.Between 1976 and 1998, in 30,000 mammals, birds, reptiles,amphibians and arthropods sampled from outbreak regions,no ebolavirus was detected apart from some genetic traces found insix rodents ( Mus setulosus and Praomys) and one shrew (Sylvisorexollula) collected from the Central African Republic. Traces of EBOVwere detected in the carcasses of gorillasand chimpanzees duringoutbreaks in 2001 and 2003, which later became the source ofhuman infections. However, the high lethality from infection inthese species makes them unlikely as a natural reservoir.DiagnosisOther diseases that should be ruled out before a diagnosis of EVDcan be made include: malaria, typhoid fever, shigellosis, cholera,leptospirosis, plague, rickettsiosis, relapsing fever, meningitis,hepatitis and other viral haemorrhagic fevers.


8
http://en.wikipedia.org/wiki/Bathttp://en.wikipedia.org/wiki/Natural_reservoirhttp://en.wikipedia.org/wiki/Arthropodhttp://en.wikipedia.org/wiki/Index_casehttp://en.wikipedia.org/wiki/Gabonhttp://en.wikipedia.org/wiki/Republic_of_the_Congohttp://en.wikipedia.org/wiki/Hypsignathus_monstrosushttp://en.wikipedia.org/wiki/Hypsignathus_monstrosushttp://en.wikipedia.org/wiki/Hypsignathus_monstrosushttp://en.wikipedia.org/wiki/Epomops_franquetihttp://en.wikipedia.org/wiki/Epomops_franquetihttp://en.wikipedia.org/wiki/Epomops_franquetihttp://en.wikipedia.org/wiki/Myonycteris_torquatahttp://en.wikipedia.org/wiki/Myonycteris_torquatahttp://en.wikipedia.org/wiki/Myonycteris_torquatahttp://en.wikipedia.org/wiki/Myonycteris_torquatahttp://en.wikipedia.org/wiki/Bangladeshhttp://en.wikipedia.org/wiki/Arthropodhttp://en.wikipedia.org/wiki/Mus_setulosushttp://en.wikipedia.org/wiki/Mus_setulosushttp://en.wikipedia.org/wiki/Praomyshttp://en.wikipedia.org/wiki/Praomyshttp://en.wikipedia.org/wiki/Shrewhttp://en.wikipedia.org/wiki/Sylvisorex_ollulahttp://en.wikipedia.org/wiki/Sylvisorex_ollulahttp://en.wikipedia.org/wiki/Central_African_Republichttp://en.wikipedia.org/wiki/Gorillahttp://en.wikipedia.org/wiki/Gorillahttp://en.wikipedia.org/wiki/Central_African_Republichttp://en.wikipedia.org/wiki/Sylvisorex_ollulahttp://en.wikipedia.org/wiki/Sylvisorex_ollulahttp://en.wikipedia.org/wiki/Shrewhttp://en.wikipedia.org/wiki/Praomyshttp://en.wikipedia.org/wiki/Mus_setulosushttp://en.wikipedia.org/wiki/Arthropodhttp://en.wikipedia.org/wiki/Bangladeshhttp://en.wikipedia.org/wiki/Myonycteris_torquatahttp://en.wikipedia.org/wiki/Myonycteris_torquatahttp://en.wikipedia.org/wiki/Epomops_franquetihttp://en.wikipedia.org/wiki/Hypsignathus_monstrosushttp://en.wikipedia.org/wiki/Republic_of_the_Congohttp://en.wikipedia.org/wiki/Gabonhttp://en.wikipedia.org/wiki/Index_casehttp://en.wikipedia.org/wiki/Arthropodhttp://en.wikipedia.org/wiki/Natural_reservoirhttp://en.wikipedia.org/wiki/Bat


10/17

29-08-2014

Ebola virus infections can be diagnosed definitively in a laboratorythrough several types of tests:antibody-capture enzyme-linked immunosorbent assay (ELISA)antigen detection testsserum neutralization testreverse transcriptase polymerase chain reaction (RT-PCR) assayelectron microscopyvirus isolation by cell culture.Samples from patients are an extreme biohazard risk; testingshould be conducted under maximum biological containmentconditions.Vaccine and treatment

No licensed vaccine for EVD is available. Several vaccines are beingtested, but none are available for clinical use.Severely ill patients require intensive supportive care. Patients arefrequently dehydrated and require oral rehydration with solutionscontaining electrolytes or intravenous fluids.No specific treatment is available. New drug therapies are beingevaluated.Natural host of Ebola virusIn Africa, fruit bats, particularly species of the generaHypsignathusmonstrosus, Epomops franqueti and Myonycteris torquata, are consideredpossible natural hosts for Ebola virus. As a result, the geographicdistribution of Ebolaviruses may overlap with the range of the fruitbats.Ebola virus in animalsAlthough non-human primates have been a source of infection forhumans, they are not thought to be the reservoir but rather anaccidental host like human beings. Since 1994, Ebola outbreaksfrom the EBOV and TAFV species have been observed inchimpanzees and gorillas.RESTV has caused severe EVD outbreaks in macaque monkeys(Macaca fascicularis) farmed in Philippines and detected inmonkeys imported into the USA in 1989, 1990 and 1996, and inmonkeys imported to Italy from Philippines in 1992.


9


11/17

29-08-2014

Since 2008, RESTV viruses have been detected during severaloutbreaks of a deadly disease in pigs in Peoples Republic of Chinaand Philippines. Asymptomatic infection in pigs has been reportedand experimental inoculations have shown that RESTV cannotcause disease in pigs.

Jeenatara BegumAssistant Professor

GNIPST

DISEASE RELATED BREAKING NEWS

Ebola virus disease, West Africa (28 th August,

2014)The total number of probable and confirmed cases in the currentoutbreak of Ebola virus disease (EVD) in the four affectedcountries as reported by the respective Ministries of Health ofGuinea, Liberia, Nigeria, and Sierra Leone is 3069, with 1552deaths.The outbreak continues to accelerate. More than 40% of the totalnumber of cases have occurred within the past 21 days. However,

most cases are concentrated in only a few localities.The overall case fatality rate is 52%. It ranges from 42% in SierraLeone to 66% in Guinea.A separate outbreak of Ebola virus disease, which is not related tothe outbreak in West Africa, was laboratory-confirmed on 26August by the Democratic Republic of Congo (DRC) and isdetailed in a separate edition of the Disease Outbreak News. Read more

UPCOMING EVENTS5th International Conference on Stem Cells and Cancer 2014, JNUConvention Centre, New Delhi, India from 8-10 November, 2014


10
http://www.who.int/csr/don/2014_08_28_ebola/en/http://www.who.int/csr/don/2014_08_28_ebola/en/http://d/Jeenat/Bulletin%2034.3_1/New%20Folder/UPCOMING%20EVENTS.docxhttp://d/Jeenat/Bulletin%2034.3_1/New%20Folder/UPCOMING%20EVENTS.docxhttp://www.who.int/csr/don/2014_08_28_ebola/en/


12/17

29-08-2014

DRUGS UPDATES

FDA Approves New Indication for Promacta(eltrombopag) for Severe Aplastic Anemia: (26 th August, 2014)GlaxoSmithKline plc (LSE/NYSE: GSK) announced today that theU.S. Food and Drug Administration (FDA) has approved asupplemental New Drug Application (sNDA) for the once-dailyuse of Promacta (eltrombopag) in patients with severe aplasticanemia (SAA) who have had an insufficient response to

immunosuppressive therapy (IST) .Read more

CAMPUS NEWS The Freshers welcome programme was held on 14th August, 2014.Welcome 1st year students. We congratulate the following M.Pharm. final year students whohave made their positions in different pharmaceutical companies.

Anirban Banerjee (Emami Ltd.)Mahender Roy (Stadmed private Ltd.) We congratulate the following B.Pharm. final year students fortheir success.Samadrita Mukherjee (Abbott India Ltd.)Suman Sarkar (Tata Medical Centre-Apollo Pharmacy)Shrewashee Mukherjee (Fresenius Kabi-Parenteral Nutrition)Avishek Naskar (Glaxo SmithKline-Marketing)Bappaditya Manik (USV Limited)Sarbani Das (Nutri Synapzz-Marketing)Ankita Roy (Nutri Synapzz-Marketing)Rahul Mitra (B M Pharmaceuticals-Production)


11
http://www.drugs.com/promacta.htmlhttp://www.drugs.com/newdrugs/fda-approves-new-indication-promacta-eltrombopag-severe-aplastic-anemia-4077.htmlhttp://www.drugs.com/newdrugs/fda-approves-new-indication-promacta-eltrombopag-severe-aplastic-anemia-4077.htmlhttp://www.drugs.com/newdrugs/fda-approves-new-indication-promacta-eltrombopag-severe-aplastic-anemia-4077.htmlhttp://www.drugs.com/promacta.html


13/17

29-08-2014

The following B.Pharm. final year students have qualified, GPAT-2014. We congratulate them all.Utsha Sinha

Satarupa BhattacharyaSandipan SarkarPurbali Chakraborty Reminiscence, 2014(GNIPST Reunion) was held in Collegecampus on 2nd February,2014. 1st Annual Sports of GNIPST was held on 3rd February,2014 inCollege campus ground.

An industrial tour and biodiversity tour was conducted in Sikkimfor B.Pharm and B.Sc. students under the supervision of Mr. AsisBala, Ms. Jeentara Begum and Ms. Moumita Chowdhury. B.Pharm 3rd year won the GNIPST Football Champions trophy,2013. B.Pharm 3rd year won the final match 1-0 against B.Pharm 2nd year. Deep Chakraborty was the only scorer of the final.

STUDENTS SECTION WHO CAN ANSWER FIRS T ????

Which organisation was established in1958 by the merger of Defense ScienceOrganisation, Technical development

Establishment and Directorate ofTechnical development?

Buzkashi is the national sport of whichcountry?


12


14/17

29-08-2014

Answer of Previous Issues Questions A) atropine

B) barcode

Identify the person

Answer of Previous Issues ImageMaryam Mirzakhani

Send your thoughts/Quiz/Puzzles/games/write-ups or any othercontr ibutions for Students Sectionansw ers of this Section at [email protected]

EDITORS NOTE

It is a great pleasure for me to publish the 1 st issue of 37 th Volumeof GNIPST BULLETIN . All the followers of GNIPST BULLETINare able to avail the bulletin through facebook account GNIPSTbulletin I am very much thankful to all the GNIPST members andreaders who are giving their valuable comments, encouragementsand supports. I am also thankful to Dr. Abhijit Sengupta , Directorof GNIPST for his valuable advice and encouragement. Specialthanks to Dr. Prerona Saha, Mr. Debabrata Ghosh Dastidar


13
mailto:[email protected]:[email protected]:[email protected]


15/17

29-08-2014

and Mr. Soumya Bhattacharya for their kind co-operation andtechnical supports. Thank you Mr. Soumya Bhattacharya for thequestionnaires of the student section. An important part of the

improvement of the bulletin is the contribution of the readers. Youare invited to send in your write ups, notes, critiques or any kind ofcontribution for the forthcoming special and regular issue.

ARCHIVE

Students of GNIPST organized pre puja celebration programme,Saaranyaon 7th October, 2013 in college Auditorium.

GNIPST organized a garment distribution programme on 28th September, 2013 at Dakshineswar Kali Temple and Adyapith,Kolkata. On this remarkable event about hundred people havereceived garments. More than hundred students and most of thefaculties participated on that day with lot of enthusiasm.

GNIPST celebrated World Heart Day (29th

September) andPharmacists Day (25 th September) on 25th and 26th September,2013 in GNIPST Auditorium. A seminar on Violence againstwoman and female foeticide was held on GNIPST Auditorium on25th September organized by JABALA Action ResearchOrganization. On 26 th September an intra-college Oral and Posterpresentation competition related to World Pharmacists day andHeart day was held in GNIPST. Ms. Purbali Chakraborty ofB.Pharm 4th year won the first prize in Oral Presentation. Thewinner of Poster presentation was the group of Ms. Utsa Sinha,Mr. Koushik Saha and Mr. Niladri Banerjee (B.Pharm 4th year).A good number of students have participated in both thecompetition with their valuable views.


14


16/17

29-08-2014

Teachers day was celebrated on 5 th September, 2013 by thestudents of GNIPST in GNIPST Auditorium.

Azalea exotic flower ) , the fresher welcome programme fornewcomers of GNIPST in the session 2013-14 was held on 8th August in GNIPST Auditorium. One day seminar cum teachers development programme forschool teachers on the theme of Recent Trends of Life Sciencesin Higher Education organized by GNIPST held on 29th June,2013 at GNIPST auditorium. The programme was inaugurated by

Prof . Asit Guha, Director of JIS Group, Mr. U.S. Mukherjee, DyDirector of JIS Group and Dr. Abhijit Sengupta, Director cumPrincipal of GNIPST with lamp lighting. The programme startedwith an opening song performed by the B.Pharm students of thisinstitute. The seminar consists of a series of lectures, videopresentations and poster session. On the pre lunch session 4lectures were given by Dr. Lopamudra Dutta, Mr. DebabrataGhosh Dastidar, Ms. Swati Nandy and Ms. Tamalika Chakrabortyrespectively. On their presentation the speakers enlighten therecent development of Pharmacy, Genetics and Microbiology andtheir correlation with Life Sciences. On the post lunch session,Ms. Saini Setua and Ms. Sanchari Bhattacharjee explained therecent development and career opportunities in Biotechnologyand Hospital Management. The programme was concluded withvaledictory session and certificate distribution.

About 50 Higher secondary school teachers from differentschools of Kolkata and North& South 24 Parganas district ofWest Bengal participated in this programme. A good interactivesession between participants and speakers was observed in theseminar. The seminar was a great success with the effort of


15


17/17

29-08-2014

faculties, staffs and students of our Institute. It was a uniquediscussion platform for school teachers and professional of theemerging and newer branches of Life Science.

The general body meeting of APTI, Bengal Branch has beenconducted at GNIPST on 15th June, 2012. The program startedwith a nice presentation by Dr. Pulok Kr. Mukherjee, School ofNatural Products, JU on the skill to write a good manuscript forpublication in impact journals. It was followed by nearly two hourlong discussion among more than thirty participants on differentaspects of pharmacy education. Five nonmember participantsapplied for membership on that very day.

GNIPST is now approved by AICTE and affiliated to WBUT forconducting the two years post graduate course (M.Pharm)in PHARMACOLOGY. The approved number of seat is 18.

The number of seats in B.Pharm. has been increased from 60 to120.

AICTE has sanctioned a release of grant under ResearchPromotion Scheme (RPS) during the financial year 2012-13toGNIPST as per the details below:a. Beneficiary Institution: Guru Nanak Institution of PharmaceuticalScience & Technology.

b. Principal Investigator: Dr. LopamudraDutta.c. Grant-in-aid sanctioned:Rs. 16,25000/- only

d. Approved duration:3 yearse. Title of the project: Screening and identification of potential

medicinal plant of Purulia & Bankura districts of West Bengalwith respect to diseases such as diabetes, rheumatism, Jaundice,hypertension and developing biotechnological tools for enhancingbioactive molecules in these plants.


GNIPST Bulletin 37.1

Documents

Transcript of GNIPST Bulletin 37.1